David Shapiro, Chief Medical Officer at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 1,606 shares at $115.01 ($183K) on 2019-04-03, disclosed to the SEC on 2019-04-03.
Seasonal sale ($183k) by Chief Medical Officer — this insider has traded ICPT in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $111.50 | 482 | $54K | 29.4% |
| 2 | $115.01 | 562 | $65K | 35.3% |
| 3 | $115.01 | 562 | $65K | 35.3% |
| Total | $113.96 avg | 1,606 | $183K | 100% |
| Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |
| ICPT | SELL | 2019-01-04 | $46K | — | Filing → |